Discontinued drugs in 2008: oncology drugs

被引：18
|
作者：
Williams, Robert [1 ]
机构：
[1] Canc Res UK, Drug Dev Off, London WC2A 3PX, England
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2009年 / 18卷 / 11期
关键词：
1D09C3; 4-demethylpenclomedine; ARQ-171; AZD-4992; CNF-1010; DN-101; FCE-28068; FCE-28069; folitixorin calcium; huMy9-6-DM4; INNO-305; mitumprotimut-T; MLN-8054; N-acetylcysteine; PD-0325901; phosphomannopentaose sulfate; PI-166; SGX-523; spisulosine; Symadex; tozasertib lactate; varalanib; zanolimumab; ATTRITION RATES;
D O I：
10.1517/13543780903151806
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The failure of drug candidates in clinical development remains a critical issue for the pharmaceutical and biotechnology industries. This article documents those oncology drugs discontinued in 2008 and briefly reviews reasons for termination of development. Source information was derived from a search of the Pharmaprojects database for drugs reaching phase I - III clinical trials.
引用
收藏
页码：1581 / 1594
页数：14
相关论文
共 50 条
  • [21] Discontinued dermatological drugs in 2014
    Phuong, Christina
    Maibach, Howard I.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (11) : 1483 - 1491
  • [22] Discontinued cardiovascular drugs in 2015
    Zhao, Hong-ping
    Dai, Yan
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (09) : 1093 - 1101
  • [23] Discontinued in 2013: diabetic drugs
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (12) : 1703 - 1711
  • [24] Discontinued drugs 2007: central and peripheral nervous system drugs
    Ebert, Bjarke
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 109 - 123
  • [25] Discontinued drugs in 2006: Cardiovascular drugs translational medicine perspective
    Feuerstein, Giora Z.
    Ruffolo, Robert R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1315 - 1326
  • [26] Discontinued drugs in 2006: central and peripheral nervous system drugs
    Collins, Susanne D.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (11) : 1743 - 1751
  • [27] Discontinued drugs in 2012: endocrine and metabolic
    Colca, Jerry R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1305 - 1313
  • [28] Discontinued cardiovascular drugs in 2013 and 2014
    Zhao, Hong-ping
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (08) : 1083 - 1092
  • [29] Discontinued drugs 2011: endocrine and metabolic
    Colca, Jerry R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (11) : 1619 - 1624
  • [30] Oncology drugs
    Buxeraud, Jacques
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (598): : 20 - 28
12345